Midwest Allergy and Asthma Clinic, P.C. began conducting clinical research in 1990. We have a dedicated Research Department and staff specifically trained as Certified Clinical Research Coordinators. Working closely with our physician investigators, they are uniquely qualified to assist in the management of our patients who are participating in clinical research studies.
What is research?
With a research study, participants receive investigational treatments under close supervision of the Midwest Allergy and Asthma Research Team. Our physicians were selected by various pharmaceutical companies to safely conduct the clinical trials. The clinical testing of an investigational medication is a step-by-step process that ensures each patient receives careful medical attention throughout the entire study.
All research studies are reviewed by the Food and Drug Administration (FDA) and Institutional Review Boards (IRBs). IRBs are independent committees who ensure that your rights are fully protected and that patients are not exposed to any unnecessary risks.
Four Phases of Research
Clinical trials are conducted in four phases. The Midwest Allergy and Asthma Research Department does not participate in phase one studies.
- Phase 1
The purpose of phase one clinical trials is to establish the safety and tolerance of an investigational medication in humans. Prior to phase one, the medication has not been tested in humans.
- Phase 2
The purpose of phase two clinical trials is to establish the maximum therapeutic dosage. The effectiveness of the medication for the specific population is also investigated.
- Phase 3
The purpose of phase three research studies is to determine the safety and effectiveness of the medication in a broad sample of the specific population. With a successful clinical trial, the medication is approved by the FDA.
- Phase 4
After the medication has been approved by the FDA and is on the market, phase four studies monitor the ongoing effectiveness of the drug in comparison to other medications used for similar purposes.
Although a study may not be of direct benefit to you or your child, helpful information about asthma, allergies, or respiratory diseases may result from the clinical trial. A study may also help to establish new treatments for migraines, influenza, or non-allergic rhinitis.
Since studies are investigational, there may be some unknown risks. All medications have the potential risk of an allergic reaction or may cause some side effects. Your study doctor will monitor you throughout the entire study and act in your best interest.
There is no charge for participating in a research study. The study medication, study-related procedures and study visits are provided at no charge to you or your insurance company. Most studies offer compensation for your time and effort.
We invite you to ask about available studies during your regular appointments. The study doctor and medical staff will discuss the eligibility criteria with you and can answer any questions you may have. You should feel free to discuss your medical treatment with our staff at any time during the course of your clinical trial. Your participation in a research study does not affect your routine medical care.